Invitro International 

$0.060000
3
-$0.01-7.69%Friday 14:50

Statistics

Day High
0.06
Day Low
0.06
52W High
0.16
52W Low
0.0315
Volume
2,000
Avg. Volume
9,087
Mkt Cap
1.33M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Jul 29Expected
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2020
Q2 2020
-0
-0
0
0
Expected EPS
N/A
Actual EPS
0.0005

Financials

13.88%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
879,000Revenue
122,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Icon
ICLR
Mkt Cap12.5B
ICON plc provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries, directly competing with IVRO's services in drug testing and development.
Charles River Laboratories International
CRL
Mkt Cap13.85B
Charles River Laboratories International, Inc. offers a variety of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, overlapping with IVRO's market.
IQVIA
IQV
Mkt Cap42.5B
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing in the drug development and testing sector.
Medpace
MEDP
Mkt Cap16.73B
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO), offering a range of services that compete with IVRO's offerings in the biotech and pharmaceutical sectors.
Waters
WAT
Mkt Cap41.78B
Waters Corporation provides analytical standards and instrumentation, which are essential in drug development and testing processes, competing with IVRO's analytical services.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories, Inc. offers a range of products and services for life science research and clinical diagnostics, competing in the biotechnological and pharmaceutical research space.
Mettler-Toledo International
MTD
Mkt Cap29.78B
Mettler-Toledo International Inc. specializes in precision instruments for research, development, and quality control laboratories, competing with IVRO in providing essential equipment and services for drug testing.

About

Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness. Beyond product sales, the company delivers tailored technological support for the implementation and use of the Irritection system, alongside offering independent laboratory services for irritation and corrosion assessments. Their solutions are predominantly adopted by manufacturers involved in producing surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials.
Show More
CEO
W. Richard Ulmer
Employees
5
Country
United States
ISIN
US4618531036

Listings

0 Comments

Share your thoughts

FAQs

What is Invitro International stock price today?▼
The current price of IVRO is $0.06 USD — it has decreased by -7.69% in the past 24 hours. Watch Invitro International stock price performance more closely on the chart.
What is Invitro International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Invitro International stocks are traded under the ticker IVRO.
Is Invitro International stock price growing?▼
IVRO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Invitro International has showed a -19.03% decrease.
What is Invitro International market cap?▼
Today Invitro International has the market capitalization of 1.33M
What were Invitro International earnings last quarter?▼
IVRO earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Invitro International revenue for the last year?▼
Invitro International revenue for the last year amounts to 879,000 USD.
What is Invitro International net income for the last year?▼
IVRO net income for the last year is 122,000 USD.
How many employees does Invitro International have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Invitro International located?▼
Invitro International operates in the Health & Wellness sector.
When did Invitro International complete a stock split?▼
Invitro International has not had any recent stock splits.
Where is Invitro International headquartered?▼
Invitro International is headquartered in Placentia, United States.